Identifying therapeutic targets for schizophrenia

There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...

Full description

Saved in:
Bibliographic Details
Main Author: Karli Montague-Cardoso
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Online Access:https://doaj.org/article/e8c68a00f79b4d2a84f00ab418323797
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items